Apellis Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Apellis Pharmaceuticals, Inc. has filed 1,229 SEC EDGAR filings since 21 May 2010

SEC filing history

Showing 26-50 of 1,000 matching filings.

Per page
25
Current page
2
S-8 POS File 333-229876

S-8 POS

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-263100

S-8 POS

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-236708

S-8 POS

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-236710

S-8 POS

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-269888

S-8 POS

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-253518

S-8 POS

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-277381

S-8 POS

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-285393

S-8 POS

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-293669

S-8 POS

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-90187

SC TO-T/A

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-90187

SC 14D9/A

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90187

SCHEDULE 13G filing

Filing date
12 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-90187

AMENDMENT NO. 2

Filing date
12 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-90187

SC 14D9/A

Filing date
12 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-90187

AMENDMENT NO. 1

Filing date
06 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-90187

SC 14D9/A

Filing date
06 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 May 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Apr 2026
Reporting date
17 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9 File 005-90187

SC 14D9

Filing date
14 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Apr 2026
Reporting date
06 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .